Invest in the team – always. Readers of this Q&A are strongly encouraged to review the content in our December issue where FSD Pharma is featured to see just I am referring to here. FSD has had a few recent significant appointments – Dr. Raza Bokhari (previously as Interim CEO) Co-Chairman; Anthony Durkacz as Co-chairman; Zeeshan Saeed as President; Rupert Haynes, as Chief Executive Officer – a former GW Pharmaceutical Company Head of Marketing; and, David Urban as a Director of the Board. What is the significance of this restructuring and additions …. And again, what is the messaging of these appointments to investors?
Thank you! for mentioning our medical accomplishments to date. Both partnership developments you mentioned with Scicann Therapeutics (IBS research) and Canntab Therapeutics (hard form CBD Pill) are set to be proprietary medical cannabis products that FSD Pharma has partnered with for distribution and royalty agreements. Scicann therapeutics is doing clinical trials for IBS, cardiovascular and arterial disease, dementia, and anxiety. FSD Pharma holds the exclusive license in Canada for the production and distribution of a line of proprietary cannabinoid-based, patent pending and indication-specific products created by Scicann Therapeutics.
on each of these and your many other initiatives. What is the significance of your direct involvement here and how do you feel that will translate or transfer into ROI to your existing and also to your prospective investors?
FSD Pharma has continued to develop a top in class management team with each person on the board having significant value. Our most significant addons have been Dr.Raza Bokhari who brings a wealth of knowledge in global business and healthcare services. He currently serves as the Chairman & CEO of PCL, a global diagnostic provider of addiction screening and opioid prescription medication monitoring, including designer drugs and synthetic cannabinoids. Rupert Haynes now the CEO of FSD Pharma was former head of global Marketing at GW pharmaceuticals and was involved in the strategic planning & development of Epidiolex the only FDA-approved cannabinoid treatment for seizures associated with Lennox-Gastaut syndrome or Dravet syndrome. David urban is an accomplished American business and government relations executive. Mr. Urban’s most notable accomplishments include Chief of Staff for United States Senator Arlen Specter (R-PA) and more recently, served as a senior advisor to the Current United States President. Politico named Mr. Urban one of the 30 most powerful people in President Trump’s Washington.
130